Anthony W. Tolcher, Tanya B. Dorff, Sumiko Okubo, Linu Abraham, Regina Reilly, Claudina Stevenson, Song Wang, Ana Cole, Sarah Mudd, Samaneh Alaei, Yuemei Wang, David I. Quinn, Fred Saad, John D. Powderly. "Phase 1, open-label, first-in-human study of ABBV-969, a dual variable antibody-drug conjugate, in patients with metastatic castration-resistant prostate cancer.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.tps5111